Darren O Brien
Directeur/Membre du Conseil chez AEON Biopharma Sub, Inc.
Profil
Darren O Brien is currently a Director at AEON Biopharma Sub, Inc. and holds Managing Director & Partner position at Sailing Capital Advisors Hong Kong Ltd and Director position at Alphaeon 1 LLC.
He previously worked as a Director at Sailing Innovation (UK) Ltd.
Postes actifs de Darren O Brien
Sociétés | Poste | Début |
---|---|---|
Sailing Capital Advisors Hong Kong Ltd
Sailing Capital Advisors Hong Kong Ltd Investment ManagersFinance Sailing Capital Advisors Hong Kong Ltd (Sailing Capital Advisors) is a private equity subsidiary of Sailing Capital Management Co Ltd founded in 2012. The firm is headquartered in Wan Chain, Hong Kong. | Private Equity Investor | - |
Alphaeon 1 LLC
Alphaeon 1 LLC Financial ConglomeratesFinance Alphaeon 1 LLC operates as investment holding company. The company was founded in 2020 and is headquartered in Newport Beach, CA. | Directeur/Membre du Conseil | - |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Directeur/Membre du Conseil | 24/07/2023 |
Anciens postes connus de Darren O Brien
Sociétés | Poste | Fin |
---|---|---|
Sailing Innovation (UK) Ltd.
Sailing Innovation (UK) Ltd. Financial ConglomeratesFinance Sailing Innovation (UK) Ltd. operates as a British dormant company. The private company is based in London, UK. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
Sailing Capital Advisors Hong Kong Ltd
Sailing Capital Advisors Hong Kong Ltd Investment ManagersFinance Sailing Capital Advisors Hong Kong Ltd (Sailing Capital Advisors) is a private equity subsidiary of Sailing Capital Management Co Ltd founded in 2012. The firm is headquartered in Wan Chain, Hong Kong. | Finance |
Sailing Innovation (UK) Ltd.
Sailing Innovation (UK) Ltd. Financial ConglomeratesFinance Sailing Innovation (UK) Ltd. operates as a British dormant company. The private company is based in London, UK. | Finance |
Alphaeon 1 LLC
Alphaeon 1 LLC Financial ConglomeratesFinance Alphaeon 1 LLC operates as investment holding company. The company was founded in 2020 and is headquartered in Newport Beach, CA. | Finance |